Steven H. Stein - 14 Jul 2025 Form 4 Insider Report for INCYTE CORP (INCY)

Reporting relationship: EVP & Chief Medical Officer
Issuer ticker: INCY
Reported as of: 14 Jul 2025
Net transaction value: -$1,241,509
SEC form: 4
Accepted by SEC: 16 Jul 2025, 16:05:13 UTC
Prior SEC filing: 07 Jul 2025
Next SEC filing: 23 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Elizabeth Feeney, Attorney-In-Fact

Key filing fact

Steven H. Stein filed Form 4 for INCYTE CORP (INCY) on 16 Jul 2025.

Key facts

This page summarizes Steven H. Stein's Form 4 filing for INCYTE CORP (INCY).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 16 Jul 2025, 16:05.

Change

Previous filing in this sequence was filed on 07 Jul 2025.
Current net transaction value: -$1,241,509.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001673776 Primary reporting owner

Stein Steven H

Relationship: EVP & Chief Medical Officer
Address: 1801 AUGUSTINE CUT-OFF, WILMINGTON
Signature: /s/ Elizabeth Feeney, Attorney-In-Fact
Signature date: 16 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INCY transaction

Common Stock

Sale

Transaction value: $1,023,763
Shares: -14,952
Change %: -13%
Price: $68.47
Shares after: 97,466
Date: 14 Jul 2025
Ownership: Direct

INCY transaction

Common Stock

Tax liability

Transaction value: $108,819
Shares: -1,555
Change %: -1.6%
Price: $69.98
Shares after: 95,911
Date: 14 Jul 2025
Ownership: Direct
Footnotes: F1

INCY transaction

Common Stock

Tax liability

Transaction value: $108,927
Shares: -1,596
Change %: -1.7%
Price: $68.25
Shares after: 94,315
Date: 15 Jul 2025
Ownership: Direct
Footnotes: F1

INCY transaction

Common Stock

Award

Transaction value: $0
Shares: +12,277
Change %: +13%
Price: $0.000000
Shares after: 106,592
Date: 15 Jul 2025
Ownership: Direct
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INCY transaction Derivative

Performance Shares

Award

Transaction value: $0
Shares: +30,692
Change %
Price: $0.000000
Shares after: 30,692
Date: 15 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 30,692
Exercise price
Footnotes: F4

INCY transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +27,629
Change %
Price: $0.000000
Shares after: 27,629
Date: 15 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 27,629
Exercise price: $68.25
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock.

Footnote F2

Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.

Footnote F3

Including the July 15, 2025 grant, this includes an aggregate of 100,327 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.

Footnote F4

Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

Footnote F5

The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.